[1]
M. Bahi, Y. Aissaoui, A. Belhadj, Y. Qamouss, and R. Seddiki, “Hydroxyzine revealing acquired neuromuscular weakness in a patient with COVID-19 disease”, The Chronicles, vol. 9, no. 40, pp. 74-76, Jul. 2021.